摘要:第34届亚太肝脏研究协会(Asian-Pacific Association for the Study of the Liver,APASL)年会将于3月26日至3月30日在北京盛大启幕。目前会议摘要标题已公布,医脉通肿瘤科特别整理了肝胆胰肿瘤领域的中国Po
标题:Mortality Burden of HBV/HCV-related Liver Cancer: A Comparative Analysis of Temporal and Spatial Trends from 1990 to 2050
报告人:Yujiao Deng
New-ID:PP0030
标题:A persistent global inequality in HBV-related liver cancer burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021
报告人:He Li
03 Submit ID:15383
New-ID:PP0031
标题:Global Distribution and Trends of Liver Cancer due to Nonalcoholic Steatohepatitis from 1990-2021
报告人:Gang Qin
04 Submit ID:15573
New-ID:PP0032
标题:Estimates and trends in the global burden of hepatocellular carcinoma by NASH from GBD Study between 1990 to 2021
报告人:Jing Liu
05 Submit ID:16296
New-ID:PP0034
标题:The disease burden of gallbladder and biliary tract cancer from 1990-2021: a population-based observational study from 2021 GBD database
报告人:Xiaoxiao Wang
06 Submit ID:16040
New-ID:PP0038
标题:An Analysis of Gender, Age Distribution, and Temporal Trends in Cholangiocarcinoma Mortality in the United States: A Population-based Study
报告人:Xindi Huang
07 Submit ID:15104
New-ID:PP0058
标题:Study on the synergistic mechanism of photodynamic therapy combined with ferroptosis inducer to induce ferroptosis in cholangiocarcinoma
报告人:Sifan Dong
08 Submit ID:15994
New-ID:PP0077
标题:Expression of ORC1 Gene in the Histology of HBV-associated Hepatocellular Carcinoma
报告人:Qingmei Li
09 Submit ID:14124
New-ID:PP0078
标题:The association of hepatitis B virus with extrahepatic tumors, mainly pancreatic cancer
报告人:Yuchao Lu
10 Submit ID:16063
New-ID:PP0127
标题:Correlation Analysis Between HBV DNA and cccDNA Levels in Liver Tissues of HBV-HCC Patients and Tumor Markers
报告人:Jin Li
11 Submit ID:16600
New-ID:PP0134
标题:Risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance and a novel prediction model establishment
报告人:Shuaibing Ying
12 Submit ID:11500
New-ID:PP0144
标题:Correlation between FIB-4 index and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A prospective cohort study
报告人:Xuesong Gao
13 Submit ID:11655
New-ID:PP0145
标题:Dynamic assessment of liver steatosis on the risk of hepatocellular carcinoma in patients with chronic hepatitis B by ultrasound
报告人:Mingyue Xiao
14 Submit ID:12151
New-ID:PP0151
标题:Establishment of a Bile Acid-based Risk Model to Predict the Progression to Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
报告人:Xue mei Zhang
15 Submit ID:12993
New-ID:PP0153
标题:To Explore the Relationship between ESPL1 Gene and p53 Gene in HCC Patients and to Analyze Its Diagnostic Value for HCC
报告人:Yanfei Feng
16 Submit ID:16213
New-ID:PP0225
标题:HBV screening, diagnosis and treatment model for family members of HBV-related HCC patients
报告人:Peng Wang
17 Submit ID:15984
New-ID:PP0245
标题:Effectiveness and Safety of 48-Week Tenofovir Amibufenamide in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Real-World Study
报告人:Qinglei Zeng
18 Submit ID:16105
New-ID:PP0247
标题:Expression of CD161+CD8+ T Cells in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma
报告人:刘晨瑞
单位:西安交通大学第二附属医院
19 Submit ID:16216
New-ID:PP0250
标题:The diagnostic value of serum CHI3L1 in the progression of chronic liver disease and prognosis of liver cancer
报告人:Haiying Zhang
20 Submit ID:14121
New-ID:PP0262
标题:Identification of RAD51AP1 as a Key Gene in Hepatitis B Virus-Associated Hepatocellular Carcinoma
报告人:Changfeng Sun
21 Submit ID:14812
New-ID:PP0266
标题:ORC1 Protein as a Serum Marker of HBV-associated Hepatocellular Carcinoma
报告人:Su Tumei
22 Submit ID:13735
New-ID:PP0285
标题:The Risk Factors Associated with Liver Cancer and Cirrhosis in Chronic Hepatitis C Patients and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment
报告人:Jinsheng Guo
23 Submit ID:15964
New-ID:PP0294
标题:Mendelian randomization analysis reveals Hepatitis C infection is causally associated with extrahepatic cancer
报告人:刘长青
单位:北京大学肿瘤医院
24 Submit ID:13586
New-ID:PP0380
标题:Trans Fatty Acids Regulate the Growth and Proliferation of Hepatocellular Carcinoma Cells via the OPN-NF-κB Signaling Axis
报告人:Peici Yan
25 Submit ID:14053
New-ID:PP0384
标题:Trans Fatty Acids Induce the Construction of HCC-Microenvironment by Accelerating the Process of Liver Fibrosis
报告人:Xiangnan Wang
26 Submit ID:15529
New-ID:PP0414
标题:CD133 drives MASLD-related hepatocellular carcinoma and is a therapeutic target
报告人:Yasi PAN
27 Submit ID:15724
New-ID:PP0518
标题:The Influence of Metabolic Dysfunction-Associated Fatty Liver Disease on the Risk of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
报告人:Zixiang Huang
28 Submit ID:16575
New-ID:PP0526
标题:Histone Methylation as a Biomarker for MASH Progression to Hepatocellular Carcinoma
报告人:Xinlei Qi
29 Submit ID:11807
New-ID:PP0571
标题:APRI can be used as an effective predictor of liver injury in patients with hepatocellular carcinoma treated with PD-1/PD-L1 inhibitor combination therapy:A single-center retrospective study
报告人:JingMing Zhang
30 Submit ID:16266
New-ID:PP0645
标题:Single-Cell RNA Sequencing for a Rare Case of Primary Biliary Cholangitis-Associated Hepatocellular Carcinoma Reveals a Distinct Immune Landscape and Potential Therapeutic Targets
报告人:Jie Han
31 Submit ID:16719
New-ID:PP0800
标题:中医外治法治疗肝癌介入术后呃逆的研究
报告人:wei xiao guo
32 Submit ID:11785
New-ID:PP0815
标题:Avatrombopag for the treatment of immune checkpoint inhibitor/targeted therapy-related thrombocytopenia in patients with hepatocellular carcinoma: A prospective, multicenter, single-arm trial
报告人:Wang Yong Shuai
33 Submit ID:14824
New-ID:PP0915
标题:Endoscopic treatment as secondary prophylaxis ameliorates short-term mortality for acute esophagogastric variceal bleeding in older patients with cirrhotic hepatocellular carcinoma
报告人:Qi Li
34 Submit ID:13842
New-ID:PP0940
标题:Spatial Transcriptomics Integrated with Bulk RNA Sequencing Reveals the Prognostic Signatures and Immunoinfiltration in Hepatocellular Carcinoma Undergoing Immunotherapy, and Construction of Related Predictive Models Using Machine Learning
报告人:zhenyu zheng
35 Submit ID:16596
New-ID:PP0942
标题:Protein C Licenses P62/mTOR-Mediated Autophagy Activation to Drive Hepatocellular Carcinoma Progression
报告人:Shuaibing Ying
36 Submit ID:11336
New-ID:PP0943
标题:LHX3 promotes EMT process in hepatoma cell through β-catenin/TCF4 pathway
报告人:Zhonglan You
37 Submit ID:13366
New-ID:PP0944
标题:LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
报告人:YIngchao Wang
38 Submit ID:11742
New-ID:PP0945
标题:Efficacy and safety analysis of transarterial chemoembolization plus donafenib with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a prospective, single-arm, single-center, phase II clinical study
报告人:Jinpeng Li
39 Submit ID:12904
New-ID:PP0947
标题:FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription
报告人:Yuqing Xie
40 Submit ID:12929
New-ID:PP0948
标题:XPD inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells and its related mechanisms
报告人:Jie Jian
41 Submit ID:11436
New-ID:PP0949
标题:Short-term Efficacy and Safety Analysis of HAIC Combined with Targeted and Immunotherapy for Unresectable Hepatocellular Carcinoma with High-flow Hepatic Arteriovenous Fistula
报告人:Jinpeng Li
42 Submit ID:13371
New-ID:PP0950
标题:Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: Clinical implications
报告人:YIngchao Wang
43 Submit ID:13384
New-ID:PP0951
标题:Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma
报告人:Bixing Zhao
44 Submit ID:14113
New-ID:PP0952
标题:Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights from Super and Poor Survivors with Prognostic Signature Identification
报告人:Xiaoqian Xu
45 Submit ID:14116
New-ID:PP0953
标题:Role of the nucleotide excision repair function of CETN2 in the inhibition of the sensitivity of hepatocellular carcinoma cells to oxaliplatin
报告人:Hengcheng Tang
46 Submit ID:14205
New-ID:PP0954
标题:Weissella confusa inhibits liver cancer lung metastasis by suppressing the secretion of ursodeoxycholic acid (UDCA)
报告人:Shuang Li
47 Submit ID:14470
New-ID:PP0955
标题:The Chinese herbal KangXianYiAi formula attenuates hepatocellular carcinoma by regulating the bile acid transporters and YAP expression
报告人:xiaobin Zao
48 Submit ID:14628
New-ID:PP0956
标题:Sinomenine Reduces the Proliferative Activity of Hepatocellular Carcinoma by Inhibiting Trim29 Expression
报告人:Jingjing He
49 Submit ID:14802
New-ID:PP0957
标题:Hu-Qi-San suppresses Sgp19-KRas intrahepatic cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment
报告人:Huang Xiuqin
50 Submit ID:15012
New-ID:PP0958
标题:High-resolution Quantitative Reconstruction of Microvascular Architectures in Mouse Hepatocellular Carcinoma Models
报告人:Yan Zhao
51 Submit ID:13342
New-ID:PP0960
标题:The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination
报告人:Peng Chen
52 Submit ID:15298
New-ID:PP0961
标题:ACSS2-induced Acetyl-CoA accumulation and H3K27ac promotes VDAC1-mediated mitophagy and tumor growth in Hepatitis B virus-associated hepatocellular carcinoma
报告人:Shan Li
53 Submit ID:15814
New-ID:PP0965
标题:Integrated single-cell and spatial transcriptome reveal the intracellular and extracellular roles of tumor cell-derived osteopontin in promoting intrahepatic cholangiocarcinoma progression
报告人:Yuan Liang
54 Submit ID:13157
New-ID:PP0966
标题:Tumor Shrinkage Following Epclusa Treatment: Exploring Potential Role of Direct-Acting Antivirals in HCV-Related Hepatocellular Carcinoma
报告人:Haipeng Jiang
55 Submit ID:15142
New-ID:PP0967
标题:The status of cytotoxic lymphocytes before transarterial chemoembolization plus systemic terapies serves as an indicator of therapeutic efficacy and prognosis in patients with advanced hepatocellular carcinoma
报告人:Haifeng Zhou
56 Submit ID:16208
New-ID:PP0969
标题:High chloride intake inhibits the carcinogenesis and growth of hepatocellular carcinoma
报告人:Li Zhang
57 Submit ID:15516
New-ID:PP0970
标题:Up-regulated Krüppel-like factor 5 Promotes Hepatocellular Carcinoma Progression via Activating Wnt3a Signaling
报告人:Wenli Sai
58 Submit ID:16614
New-ID:PP0971
标题:Development and validation of functional liver imaging score model to predict prognosis of patients with hepatocellular carcinoma after surgical resection
报告人:Xinya Zhao
59 Submit ID:11335
New-ID:PP0973
标题:Combined DeRitis ratio and alkaline phosphatase on the Prediction of Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma
报告人:苗同国
单位:石家庄市第五医院
60 Submit ID:11716
New-ID:PP0974
标题:Development and Validation of an ESPL1-Based Risk Model for Early Detection of HBV-Related Hepatocellular Carcinoma
报告人:Luhuai Feng
61 Submit ID:13020
New-ID:PP0975
标题:Gadoxetic acid disodium (Gd-EOB-DTPA) contrast-enhanced abbreviated magnetic resonance imaging (MRI) for hepatocellular carcinoma surveillance in at-risk patients: a multi-center study in China
报告人:Lan Zhang
62 Submit ID:15447
New-ID:PP0976
标题:Extracellular volume (ECV) derived from spectral CT to assess vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study
报告人:Yongquan Yu
63 Submit ID:13023
New-ID:PP0977
标题:Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus
报告人:Lan Zhang
64 Submit ID:14223
New-ID:PP0978
标题:Construction and evaluation of prognostic model of liver cancer based on triple serum fluorescence indicator of aptamer
报告人:Jianming Zhou
65 Submit ID:14306
New-ID:PP0979
标题:A Digital Risk Stratification Management Platform Based on GAAD Score Improves the Early Diagnosis of Hepatocellular Carcinoma (HCC) through Screening Chronic Hepatitis B (CHB) Patients: A Real-World Study in China
报告人:Yong Li
66 Submit ID:14310
New-ID:PP0980
标题:Causal Associations between Sarcopenia-Related Traits and Primary Liver Cancer in the European Population: A Mendelian Randomization Study
报告人:Zuohu Niu
67 Submit ID:13022
New-ID:PP0981
标题:Differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma based on MRI correlated with serum tumor markers: A multi-center study in China
报告人:Lan Zhang
68 Submit ID:15432
New-ID:PP0982
标题:A nomogram model for predicting the survival of patients with alcohol-related hepatocellular carcinoma
报告人:Chang Guo
699
Submit ID:15495
New-ID:PP0983
标题:Comparison of Hotgen Biotech and Abbott Architect in Measuring AFP and PIVKA-II for Hepatocellular Carcinoma Diagnosis
报告人:YUAN HUANG
70 Submit ID:15765
New-ID:PP0984
标题:A nomogram based on clinical indicators and enhanced CT for prediction of VETC metastatic pattern in hepatocellular carcinoma
报告人:Yongquan Yu
71 Submit ID:15798
New-ID:PP0985
标题:Dynamic PET/CT images and deep learning assessment for early diagnosis of liver cancer induced by DEN/CCl4 in mice
报告人:Junnan Wang
72 Submit ID:15798
New-ID:PP0986
标题:Radiographic response combined Radiomic features response predict pathologic complete response to systemic therapy in hepatocellular carcinoma
报告人:ShiQi Zhou
73 Submit ID:11672
New-ID:PP0994
标题:Myasthenia gravis-like symptoms following immune checkpoint inhibitor therapy for hepatocellular carcinoma: a case report
报告人:Fushuang Ha
74 Submit ID:12854
New-ID:PP0995
标题:Developing a signature based on necroptosis-related lncRNAs to predict the prognosis and immunotherapy response of hepatocellular carcinoma
报告人:Yao Liu
75 Submit ID:13292
New-ID:PP0996
标题:ERAL1 down-regulates NDUFV1 through m6A reader IGF2BP2 to inhibit mitochondrial ATP synthesis and metastasis in hepatoma cells
报告人:Li Zhou
76 Submit ID:13992
New-ID:PP0998
标题:Risk Factors for Early-Onset HCC in Patients with HBV Infection
报告人:关玉娟
单位:广州医科大学附属市八医院
77 Submit ID:14450
New-ID:PP0999
标题:Lipid Phosphatase SAC1 Suppresses the Metastasis of Hepatocellular Carcinoma by Dual Activation of PI4P/NF2-MST1/2-LAST1/2-YAP Axis and Promoting YAP Cytoplasmic Retention through Interacting with 14-3-3
报告人:Haihuan Tang
78 Submit ID:15105
New-ID:PP1003
标题:Conversion therapy and R0 resection for pancreatic cancer with multiple liver metastases:A case report
报告人:an jiang
79 Submit ID:15127
New-ID:PP1004
标题:Analysis on clinicopathological characteristics and prognostic factors of gallbladder carcinoma from adenoma
报告人:Ruiqi Zou
80 Submit ID:16385
New-ID:PP1006
标题:Construction and validation of a novel recurrence risk model for postoperative patients with stage I intrahepatic cholangiocarcinoma
报告人:Hui Wang
81 Submit ID:15436
New-ID:PP1007
标题:Efficacy and safety in Advanced Cholangiocarcinoma Using different doses of Lenvatinib Combined with PD-1 and GEMOX:A Retrospective Analysis of Real-World Evidence
报告人:Jiamin Chen
82 Submit ID:15128
New-ID:PP1008
标题:Clinicopathological Features and Survival Outcomes of Pure Gallbladder Squamous Cell Carcinoma: A China experience
报告人:RuiQi Zou
83 Submit ID:16383
New-ID:PP1010
标题:Mediation analysis of surgery in prognosis among postoperative intrahepatic cholangiocarcinoma patients
报告人:Hui wang
84 Submit ID:13379
New-ID:PP1013
标题:ASAP Score as a Novel Prognostic Tool for Recurrence and Survival in Hepatitis B-related Hepatocellular Carcinoma Following Curative Resection
报告人:杨田
单位:海军军医大学第三附属医院(东方肝胆外科医院)
85 Submit ID:16587
New-ID:PP1014
标题:Profiling the Roles of MicroRNAs Associated with Cancer Stem Cells, Drug Resistance, Metastasis, and Recurrence in Hepatocellular Carcinoma: A Systematic Review, Network analysis, and Experimental Initial Verification
报告人:Yuanyuan Jiang
86 Submit ID:16598
New-ID:PP1015
标题:The Role and Mechanisms of PYCR1 in Regulating Proline Biosynthesis Through Metabolic Pathways in the Development of Intrahepatic Cholangiocarcinoma
报告人:Xincheng Xie
87 Submit ID:16628
New-ID:PP1016
标题:Mechanisms of Hepatic Progenitor Cell Aberrant Differentiation into Cancer: Factors Influencing the Transition from Cell Differentiation to Tumorigenesis
报告人:Leyi Li
88 Submit ID:14332
New-ID:PP1017
标题:Tumor Biology Characteristics Score Based on AFP and PIVKA-II Predicts Recurrence and Survival After Curative Resection for Hepatocellular Carcinoma
报告人:杨田
单位:海军军医大学第三附属医院(东方肝胆外科医院)
89 Submit ID:11416
New-ID:PP1018
标题:AKR1D1 represses hepatocellular carcinoma progression and immune evasion by reprogramming fatty acid metabolism via STAT3
报告人:Yuxi Lin
90 Submit ID:11721
New-ID:PP1019
标题:Expression of ESPL1 gene in HBV-associated HCC cancer tissues and its relationship with tumor pathological features
报告人:Qianbing Yin
91 Submit ID:11750
New-ID:PP1020
标题:Expression of NOP2 in Hepatocellular Carcinoma and Its Effects on the Proliferation, Migration, and Invasion of Liver Cancer
报告人:Hao Ding
92 Submit ID:12558
New-ID:PP1021
标题:Expression of the FCGBP Gene in Hepatocellular Carcinoma Tissues and Its Role in Prognostic Assessment
报告人:Hang Wang
93 Submit ID:12675
New-ID:PP1022
标题:Investigation of the Expression and Spatial Distribution of Acylglycerol Kinase in patients with HCC and Its Prognosis Significance
报告人:Gaixia He
94 Submit ID:12847
New-ID:PP1023
标题:PPARγ-ELOVL1-16:0-PPARγ-STIP1 as a Mechanotransduction Pathway Promoting HCC
报告人:Xingyuan Chen
95 Submit ID:13011
New-ID:PP1024
标题:The Aging and Metabolic Characteristics of Hepatocellular Carcinoma were Analyzed and The Prognostic Model was Established Based on TCGA Database
报告人:Mengru Hua
96 Submit ID:13012
New-ID:PP1025
标题:Causal Role of Immune Cells in Hepatocellular Carcinoma: a bidirectional mendelian randomization study
报告人:Yuting Liu
97 Submit ID:13017
New-ID:PP1026
标题:STAB1+ Senescent Macrophages Are Driven to Infiltrate and Uniquely Shape an Immunosuppressive Microenvironment in Hepatocellular Carcinoma
报告人:Longyang Zhou
98 Submit ID:13070
New-ID:PP1027
标题:Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Migration and Invasion in Hepatoma Cells by Up-regulating YAP Expression in Epithelial-Mesenchymal Transition (EMT)
报告人:Xiazhen Xu
99 Submit ID:16754
New-ID:PP1028
标题:Causal relationship between gut microbiota and hepatocellular carcinoma: A Mendelian randomization and case-control study
报告人:LIANG XU
100
Submit ID:13648
New-ID:PP1029
标题:AHCTF1 functions as an oncogenic factor and promotes tumor progression in hepatocellular carcinoma
报告人:Zhang Nuobei
101
Submit ID:13727
New-ID:PP1030
标题:The macrophage cytoskeletal protein AIF1 contributes to the immunosuppressive microenvironment in hepatocellular carcinoma by upregulating SPP1
报告人:Hao Cai
102
Submit ID:13814
New-ID:PP1031
标题:Endoscopic treatment as secondary prophylaxis ameliorates short-term mortality for acute esophagogastric variceal bleeding in older patients with cirrhotic hepatocellular carcinoma
报告人:Hongyan Huang
103
Submit ID:14074
New-ID:PP1033
标题:p53-regulated tsRNA-6 promotes proliferation in HCC cells by mediating DNA homologous recombination repair
报告人:Guanzi Chen
104
Submit ID:14119
New-ID:PP1034
标题:N4BP2L1 Inhibits Glycolysis in Hepatocellular Carcinoma Cells by Promoting Ubiquitination of HIF-1α
报告人:Xiaoling Liu
105
Submit ID:14271
New-ID:PP1035
标题:Dual Prognostic Impact of Preoperative Platelet Count Abnormalities on Long-term Oncologic Outcomes After Hepatic Resection for Hepatocellular Carcinoma: Insights from A Multicenter Analysis of 3,116 Patients
报告人:杨田
单位:海军军医大学第三附属医院(东方肝胆外科医院)
106
Submit ID:14459
New-ID:PP1036
标题:NOL9 Regulates β-Catenin Stability and Ribosome Biogenesis in Hepatocellular Carcinoma
报告人:Xiyao Chen
107
Submit ID:14749
New-ID:PP1037
标题:Bioinformatic Analysis of Macrophage Polarization and RNA Methylation-Associated Differentially Expressed Genes in Hepatocellular Carcinoma
报告人:KONGLI FAN
108
Submit ID:14821
New-ID:PP1038
标题:Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression
报告人:Lang Chen
109
Submit ID:15901
New-ID:PP1039
标题:Identification of Gut Microbiota and Bile Acid Metabolite Signatures for Predicting Response to Lenvatinib and Anti-PD-1 Combination Therapy in Hepatocellular Carcinoma
报告人:Jie Han
110
Submit ID:16295
New-ID:PP1040
标题:Prognostic value of N1/N2 neutrophils heterogeneity and tertiary lymphoid structure in hepatocellular carcinoma patients
报告人:Yanfei Lang
111
Submit ID:15579
New-ID:PP1041
标题:The Role of DDX10 in Hepatocellular Carcinoma Metastasis: Regulation of Ferroptosis
报告人:Mingyu Zhang
112
Submit ID:16049
New-ID:PP1042
标题:COMPREHENSIVE ANALYSIS OF THE ROLE OF TUMOR-ASSOCIATED ANTI-SMGGDS AUTOANTIBODY IN HEPATOCELLULAR CARCINOMA
报告人:WEI HOU
113
Submit ID:15427
New-ID:PP1043
标题:The mechanism of m5C methylation regulated energy metabolic reprogramming of hepatocellular carcinoma mediated by ALYREF/UGP2 signaling axis involved in tumor progression
报告人:JUAN LU
114
Submit ID:15590
New-ID:PP1044
标题:The Mechanism of Metabotropic Glutamate Receptor 5 in the Tumorigenesis, Progression and Angiogenesis of Hepatocellular Carcinoma
报告人:Jing Li
115
Submit ID:15922
New-ID:PP1045
标题:Comparison of platelet count and function between hepatocellular carcinoma and liver cirrhosis
报告人:Meng Zhang
116
Submit ID:16140
New-ID:PP1046
标题:A PAN-CANCER ANALYSIS OF THE ROLE OF ZC3HAV1 IN HUMAN CANCERS
报告人:WEI HOU
117
Submit ID:16371
New-ID:PP1047
标题:KRI1 Promotes Hepatocellular Carcinoma Progression by Affecting the Structure and Function of Nucleoli through Liquid-Liquid Phase Separation
报告人:Yu Lu
118
Submit ID:16274
New-ID:PP1048
标题:PAN‑CANCER ANALYSIS OF CAMSAP FAMILY AND UNRAVELLING THE ONCOGENIC ROLE IN HEPATOCELLULAR CARCINOMA
报告人:WEI HOU
119
Submit ID:15980
New-ID:PP1050
标题:AN INTEGRATED ANALYSIS OF THE ROLE OF tsRNA-Thr-5-0015 IN HUMAN TUMORS ACROSS MULTIPLE CANCER TYPES
报告人:WEI HOU
120
Submit ID:14703
New-ID:PP1051
标题:Development and validation of pyruvate metabolism associated gene signatures to predict prognosis and immunotherapy response in hepatocellular carcinoma
报告人:Ning Wang
121
Submit ID:16190
New-ID:PP1052
标题:INTEGRATED BIOINFORMATIC ANALYSIS OF THE ROLE OF WNK1 IN HEPATOCELLULAR CARCINOMA
报告人:WEI HOU
122
Submit ID:15180
New-ID:PP1053
标题:Matrine improves sorafenib resistance in hepatocellular carcinoma by regulating cell cycle, mitochondrial function, and epithelial-mesenchymal transition through inhibiting the Notch1 signaling pathway
报告人:Man Zhao
123
Submit ID:16567
New-ID:PP1054
标题:Hepatic Arterial Infusion Chemotherapy with mFOLFOX in Advanced Gallbladder Cancer: An Approach with Potential for Conversion and Enhanced Survival
报告人:Liu Ying
124
Submit ID:11675
New-ID:PP1056
标题:Comparison of the efficacy and safety of HAIC combined with Camrelizumab and Apatinib versus TACE in the treatment of intermediate-advanced HCC
报告人:Haojie Zhang
125
Submit ID:13090
New-ID:PP1057
标题:Transcatheter arterial chemoembolization combined with immune checkpoint inhibitors plus molecular targeted therapy after 125I irradiation stent placement in patients with hepatocellular carcinoma and main portal vein tumor thrombosis: a multicenter prope
报告人:Junhao Mei
126
Submit ID:13546
New-ID:PP1058
标题:Research Trends and Hotspots in Copper Metabolism in Hepatocellular Carcinoma: A Visual Analysis Based on Web of Science
报告人:Yi Zhang
127
Submit ID:13768
New-ID:PP1059
标题:Prediction of Response to Hepatic Arterial Infusion of Raltitrexed and Oxaliplatin (Ralox-HAIC) combined with lenvatinib and camrelizumab for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Prospective, Single-arm clinical study
报告人:袁国盛
单位:南方医科大学南方医院
128
Submit ID:13858
New-ID:PP1060
标题:Evaluation of the efficacy of interventional therapy combined with/without targeted and immunotherapy in patients with Child-Pugh B hepatocellular carcinoma and analysis of the beneficiary population: a single-center, retrospective study
报告人:Xuwei Guo
129
Submit ID:14062
New-ID:PP1061
标题:Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma
报告人:Quan Wang
130
Submit ID:14720
New-ID:PP1062
标题:Efficacy of sequential radiotherapy after the combination of transcatheter arterial chemoembolization with lenvatinib and anti-PD-1 antibodies for unresectable hepatocellular carcinoma
报告人:Xiangye Ou
131
Submit ID:14453
New-ID:PP1063
标题:Impact of Switching from ETV to TDF or TAF on the 3-Year Recurrence Rate After RFA Treatment in HBV-Related HCC Patients
报告人:Xue Zhang
132
Submit ID:14813
New-ID:PP1064
标题:Prognostic Value of Systemic Immune-Inflammatory Index Combined with Prognostic Nutritional Index in Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization, Lenvatinib and PD-1 Inhibitors
报告人:Zhenxin Zeng
133
Submit ID:15435
New-ID:PP1069
标题:Efficacy and Safety of Regorafenib vs. Regorafenib Combined with PD-1 Inhibitors as a Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma:A Retrospective Analysis of Real-World Evidence
报告人:Weihong Ma
134
Submit ID:15434
New-ID:PP1071
标题:Survival analysis of hepatic arterial infusion chemotherapy on progression-free survival in advanced hepatocellular carcinoma with portal vein tumor thrombus
报告人:Mengwen He
135
Submit ID:15355
New-ID:PP1072
标题:Peripheral immune features synergizing neutrophil-to-lymphocyte ratio in prediction of poor survival of hepatocellular carcinoma after thermal ablation
报告人:Fangying Fan
136
Submit ID:16469
New-ID:PP1073
标题:Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration
报告人:Donghao Yin
137
Submit ID:16588
New-ID:PP1074
标题:“白花蛇舌草-半枝莲”治疗原发性肝癌的机制研究:基于网络药理学、分子对接及体外实验验证
报告人:徐朦
单位:南方医科大学
138
Submit ID:16571
New-ID:PP1075
标题:Decoding Glycogen Metabolism in HCC: A novel Prognostic Biomarkers and Therapeutic Targets
报告人:Anna Li
139
Submit ID:16744
New-ID:PP1076
标题:Long-term Prognostic Impact of Traditional Chinese Medicine on Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Retrospective Cohort Study
报告人:ping xue zhang
140
Submit ID:16624
New-ID:PP1077
标题:Impact of Aerobic Glycolysis on the Tumor Microenvironment in Hepatocellular Carcinoma
报告人:Mengzhuo Liu
141
Submit ID:16584
New-ID:PP1078
标题:Adjuvant transarterial chemoembolization after truly curative resection does not improve survival of patients with hepatocellular carcinoma at high risk of recurrence: a target trial emulation study
报告人:钟鉴宏
单位:广西医科大学附属肿瘤医院
142
Submit ID:11833
New-ID:PP1079
标题:ERRα promotes HCC cell progression via PHF5A/PI3K/AKT signaling pathway
报告人:Xiang Cai
143
Submit ID:11916
New-ID:PP1080
标题:Single-cell RNA sequencing revealed that the enrichment of TPI1+ malignant hepatocytes was linked to HCC metastasis and immunosuppressive microenvironment
报告人:Yuxin Liang
144
Submit ID:12877
New-ID:PP1081
标题:Impact of Jinlong Capsule on Prognosis of Patients with Hepatocellular Carcinoma: A Propensity Score Matching Study
报告人:Ke Shi
145
Submit ID:12903
New-ID:PP1082
标题:Novel cellular senescence related molecular subtypes and prognostic characteristics of hepatocellular carcinoma
报告人:Yuling Liang
146
Submit ID:12908
New-ID:PP1083
标题:raditional Chinese Medicine in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus
报告人:Wanxin Shi
147
Submit ID:13816
New-ID:PP1084
标题:Preoperative Prognostic Model Combining Tumor Burden Score and Tumor Markers to Predict Long-term Outcomes Following Hepatectomy for Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis
报告人:JUN FU
148
Submit ID:14486
New-ID:PP1085
标题:Glycodeoxycholic acid stimulates antitumor immune response by driving macrophages toward M1 phenotype in hepatocellular carcinoma
报告人:Mingxia Deng
149
Submit ID:14780
New-ID:PP1086
标题:
Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma
报告人:Xiaoli Zhang
150
Submit ID:15059
New-ID:PP1087
标题:A m6A-Altering Variant of MRPL34 Predisposes to Hepatocellular Carcinoma via Regulating Oxidative Phosphorylation
报告人:Jiaxuan Chen
151
Submit ID:15203
New-ID:PP1089
标题:A case of intrahepatic bile duct papillary tumor with invasive adenocarcinoma
报告人:Linhui Hu
152
Submit ID:14359
New-ID:PP1091
标题:Impact of Regular Surveillance Compliance on Survival Outcomes After Curative Resection for Hepatocellular Carcinoma
报告人:杨田
单位:海军军医大学第三附属医院(东方肝胆外科医院)
153
Submit ID:16684
New-ID:PP1092
标题:Hepatic arterial infusion chemotherapy sequential transarterial embolization combined with lenvatinib and tislelizumab in patients with high-risk unresectable hepatocellular carcinoma: an update analysis of a phase 2 trial
报告人:钟鉴宏
单位:广西医科大学附属肿瘤医院
154
Submit ID:16712
New-ID:PP1093
标题:Risk Factors for Extrahepatic Metastasis after Microwave Ablation of Hepatocellular Carcinoma
报告人:Xueqin Tian
155
Submit ID:13818
New-ID:PP1094
标题:A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma
报告人:JUN FU
156
Submit ID:14827
New-ID:PP1095
标题:Case Report: Laparoscopic Hepatectomy for Recurrent Hepatocellular Carcinoma Following Two Previous Surgical Interventions
报告人:Chenfenglin Yang
157
Submit ID:14058
New-ID:PP1096
标题:Safety and Efficacy of Cryoablation Plus Lenvatinib versus TACE Plus Lenvatinib in Unresectable Hepatocellular Carcinoma
报告人:常秀娟
单位:中国人民解放军总医院第五医学中心
158
Submit ID:14833
New-ID:PP1097
标题:Case Report: Surgical Management of Synchronous Double Primary Cancers in the Liver and Duodenum
报告人:Chenfenglin Yang
159
Submit ID:15302
New-ID:PP1099
标题:Novel LPS-A4 score as a predictive model of hepatocellular carcinoma development in patients with chronic hepatitis B
报告人:Jingjing Song
160
Submit ID:15233
New-ID:PP1100
标题:The 15-year Prognostic Analysis of Solitary Hepatocellular Carcinoma No More Than 5cm Treated by Microwave Ablation : Primary HCC versus Local Tumor Progression
报告人:Yannan Qiao
161
Submit ID:15750
New-ID:PP1101
标题:Exosome miR-509-3p as a Novel Therapeutic Strategy Inhibits Metastasis of Hepatocellular Carcinoma via APOD/Wnt2B signaling pathway
报告人:Tao Li
162
Submit ID:16722
New-ID:PP1102
标题:TACE with or without Lenvatinib as Adjuvant Therapy for HCC with microvascular invasion (MVI) or Portal Vein Thrombus(Cheng’s I/II):A Single-Center, Prospective, Non-Randomized Cohort Study
报告人:朱成佩
单位:首都医科大学附属北京佑安医院
163
Submit ID:15264
New-ID:PP1103
标题:Survival benefit of hepatectomy after complete or partial response to conversion therapy in unresectable hepatocellular carcinoma: a multi-center study
报告人:DaLong Yang
164
Submit ID:16427
New-ID:PP1104
标题:Reversal of CD8+ T Cell Exhaustion Phenotype in Hepatocellular Carcinoma Models by Yangyin-Fuzheng-Jiedu Formula
报告人:Zimeng Shang
165
Submit ID:16667
New-ID:PP1106
标题:Multi-kingdom gut microbiota in predicting severe immune-related adverse events in advanced hepatobiliary cancers
报告人:朱成佩
单位:首都医科大学附属北京佑安医院
166
Submit ID:16671
New-ID:PP1107
标题:Traditional Chinese Medicine in Patients with Hepatocellular Carcinoma and anemia
报告人:Wanxin Shi
167
Submit ID:12336
New-ID:PP1108
标题:Efficacy and Safety of Transcatheter Arterial Chemoembolisation Combined with Lenvatinib plus Anti-PD1 Inhibitors versus Transcatheter Arterial Chemoembolisation Alone for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
报告人:Xiangye Ou
168
Submit ID:14139
New-ID:PP1110
标题:Combining with immunotherapy is a promising modality of regorafenib treatment in patients with unresectable hepatocellular carcinoma
报告人:李天翔
单位:青岛大学附属医院崂山院区
169
Submit ID:14286
New-ID:PP1111
标题:FSP1 inhibitor icFSP1 sensitizes hepatocellular carcinoma to Lenvatinib by activating
报告人:Congyue Zhang
170
Submit ID:14461
New-ID:PP1112
标题:Basing on clinical-radiologic model to predict the efficacy and prognosis of systemic therapy for hepatocellular carcinoma
报告人:谢婵
单位:中山大学附属第三医院
171
Submit ID:15908
New-ID:PP1116
标题:The efficacy and safety of sintilimab as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative hepatic resection: a prospective, single-arm, multicentric cohort study
报告人:JiaYong Su
172
Submit ID:15913
New-ID:PP1117
标题:The efficacy and safety of camrelizumab as adjuvant therapy in hepatocellular carcinoma patients at high-risk of recurrence after resection
报告人:leiPo Lin
173
Submit ID:15929
New-ID:PP1118
标题:Prognostic factors and an innovative nomogram model for hepatocellular carcinoma patients at high-risk of recurrence after resection with adjuvant PD-1 inhibitors
报告人:JiaYong Su
174
Submit ID:15976
New-ID:PP1119
标题:Immune Checkpoint Inhibitors plus Targeted Therapy for Hepatocellular Carcinoma with Extrahepatic Metastasis: a multicentric retrospective study
报告人:ZhuJian Deng
175
Submit ID:16141
New-ID:PP1120
标题:Radiotherapy with or without Immune checkpoint inhibitors and tyrosine kinase inhibitors in Hepatocellular Carcinoma involving major portal vein and/or inferior vena cava tumor thrombus: a retrospective cohort study
报告人:QianQian Tang
176
Submit ID:15314
New-ID:PP1122
标题:Silibinin suppresses HCC metastasis via regulating Trx-LIN00152-ANGPT1 signaling pathway
报告人:Yuxin Liang
177
Submit ID:15920
New-ID:PP1124
标题:Drug type of adjuvant PD-1 inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: a prospective, multicentric cohort study
报告人:JiaYong Su
178
Submit ID:16033
New-ID:PP1125
标题:Discontinuation of targeted and immunotherapy do not increase the re-bleeding rate after endoscopic treatment for gastroesophageal variceal bleeding in patients with advanced liver cancer
报告人:Wang Huishan
179
Submit ID:15455
New-ID:PP1126
标题:Effect of TACE combined with tislelizumab on patients with advanced liver cancer and influencing factors of prognosis
报告人:Gang Wu
180
Submit ID:15474
New-ID:PP1127
标题:SIRPα promotes tumor immune escape in hepatocellular carcinoma by inducing T cell apoptosis
报告人:Xue Zhang
181
Submit ID:16665
New-ID:PP1129
标题:Research Progress on New Metastatic Mode Vessels That Encapsulate Tumor Clusters Pattern of Hepatocellular Carcinoma
报告人:huiyang fan
182
Submit ID:16372
New-ID:PP1135
标题:Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy
报告人:张达利
单位: 中国人民解放军总医院第五医学中心
183
Submit ID:11676
New-ID:PP1141
标题:Novel non-invasive liver reserve and fibrosis signature to evaluate severe post-hepatectomy liver failure in patients with hepatocellular carcinoma
报告人:Feng Zhang
184
Submit ID:14295
New-ID:PP1143
标题:The Safety and Feasibility of the "Pan-Gate Theory" Combined with "Regional Hepatic Inflow Occlusion" in Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Single-Arm, Retrospective Study
报告人:Chenfenglin Yang
185
Submit ID:15607
New-ID:PP1146
标题:Exploration of the therapeutic effect and mechanism of intestinal microbiota transplantation combined with PD-1 inhibitors on liver cancer
报告人:Xiaoxiong Hu
186
Submit ID:15493
New-ID:PP1153
标题:Progression-free survival as a surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma: a multicentric retrospective study
报告人:DaLong Yang
187
Submit ID:14049
New-ID:PP1158
标题:Transplantation versus hepatectomy for Hepatocellular carcinoma ≤2cm: The experience of single center
报告人:xuguang Hu
188
标题:Multi-omics characterization of autophagy-related molecules in liver cancer
报告人:Lin Ye
标题:A CT-based deep learning radiomics scoring system for predicting the prognosis to repeat TACE in patients with hepatocellular carcinoma: A multicenter cohort study
报告人:Yanmei Dai
备注:排名不分先后,按照摘要号进行
如有遗漏或任何问题,请给我们留言~
撰写:Aurora
排版:Aurora
执行:Babel
医脉通是专业的在线医生平台,“感知世界医学脉搏,助力中国临床决策”是平台的使命。医脉通旗下拥有「临床指南」「用药参考」「医学文献王」「医知源」「e研通」「e脉播」等系列产品,全面满足医学工作者临床决策、获取新知及提升科研效率等方面的需求。本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容,不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的,本平台不承担相关责任。本平台对发布的内容,并不代表同意其描述和观点。若涉及版权问题,烦请权利人与我们联系,我们将尽快处理。
来源:医脉通肿瘤科